trending Market Intelligence /marketintelligence/en/news-insights/trending/q53fj0pzm9usthfo6cntpa2 content esgSubNav
In This List

Insys Therapeutics names independent director

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Insys Therapeutics names independent director

Chandler, Ariz.-based Insys Therapeutics Inc. appointed Elizabeth Bohlen as an independent board member.

Bohlen currently serves as the COO of the Archdiocese of Chicago, where she oversees the organization's administrative functions.

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes drugs and drug delivery systems.